🧬 The AI-Native Bio-Enterprise: Mapping the Next Decade of Personalized Medicine R&D

Welcome to AI Unraveled, Your daily briefing on the real world business impact of AI

The cost of sequencing a human genome has plummeted, but the challenge remains interpretation. We will explore how large AI models are moving from assisting diagnostics to actively designing novel drugs and personalized treatments, and what this means for enterprise R&D budgets and ethical guidelines.

Setting the stage:

Why is AI essential for genomics now?

What is the current bottleneck in drug discovery?

How are LLMs being fine-tuned for chemical and biological structures?

Specific AI applications that are cutting discovery time.

How is AI used in de novo protein design?

What is a "digital twin" of a patient, and how does it speed up clinical tr ...